Skip to main content

Table 3 Risk factor for case-fatality: logistic regression analysis

From: The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study

Factor

n

%

Unadjusted

OR(95% CI)

Adjusted

OR(95% CI)

Age(year)

< 40

113

44.3

1.00

1.00

 

≥ 40

43

46.7

1.10(0.684-1.779)

1.033(0.529-2.018)

Sex

Male

77

43.8

1.00

1.00

 

female

79

46.2

1.10(0.723-1.686)

1.033(0.566-1.887)

Address

Addis Ababa

133

50.8

1.00

1.00

 

Outside Addis Ababa

23

27.1

0.360(0.210-0.615)

0.282(0.127-0.630)

History of ART

treatment

Yes

21

38.9

1.00

1.00

 

No

135

46.1

1.343(0.742-2.430)

1.1(0.506-2.393)

Cotrimoxazole

(prophylaxis)

Yes

8

53.3

1.00

1.00

 

No

148

44.6

0.704(0.249-1.986)

0.992(0.266-3.705)

Altered sensorium

Yes

99

52.9

1.00

1.00

 

No

57

35.6

0.492(0.319-0.758)

0.514(0.288-0.916)

Seizure

Yes

65

54.6

1.00

1.00

 

No

91

39.9

0.552(0.353-0.863)

0.519(0.288-0.935)

Clinical stage of HIV infection

Stage iii

3

20

1.00

1.00

 

Stage iv

153

46.1

3.419(0.947-12.339)

2.069(0.370-11.562)

CD4 count(/mm3)

< 200

85

42.3

1.00

1.00

 

≥ 200

6

26.1

0.482(0.182-1.273)

0.572(0.205-1.595)

  1. ART antiretroviral treatment, HIV human immunodeficiency virus CD 4 cluster of differentiation 4